Repligen Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGEN Nasdaq 2836 https://www.repligen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Repligen Corp

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum - Mar 14th, 2023 11:30 am
Repligen Corporation (NASDAQ:RGEN) Q4 2022 Earnings Call Transcript - Feb 23rd, 2023 11:28 pm
Repligen's (RGEN) Q4 Earnings and Revenues Beat Estimates - Feb 23rd, 2023 6:41 pm
Repligen Full Year 2022 Earnings: EPS Beats Expectations - Feb 23rd, 2023 10:54 am
Repligen (RGEN) Q4 Earnings and Revenues Surpass Estimates - Feb 22nd, 2023 1:55 pm
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results - Feb 22nd, 2023 12:30 pm
Why Repligen Corporation (NASDAQ:RGEN) Could Be Worth Watching - Feb 20th, 2023 11:34 am
Repligen Appoints Martin D. Madaus to Board of Directors - Feb 9th, 2023 12:30 pm
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results - Feb 8th, 2023 12:30 pm
Repligen (NASDAQ:RGEN) stock performs better than its underlying earnings growth over last five years - Jan 21st, 2023 2:51 pm
Moderna (MRNA) Soars 3.3%: Is Further Upside Left in the Stock? - Jan 19th, 2023 8:10 am
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Jan 13th, 2023 1:30 pm
Why Shares of Repligen Rose This Week - Jan 12th, 2023 10:00 pm
HZNP vs. RGEN: Which Stock Is the Better Value Option? - Jan 12th, 2023 4:40 pm
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference - Jan 3rd, 2023 12:30 pm
If EPS Growth Is Important To You, Repligen (NASDAQ:RGEN) Presents An Opportunity - Dec 21st, 2022 3:56 pm
Should You Invest in Repligen Corporation (RGEN)? - Dec 19th, 2022 2:02 pm
Despite Attractive End Markets, Analyst Outlines Concerns For Repligen Stock - Dec 7th, 2022 6:40 pm
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue? - Dec 1st, 2022 4:31 pm
BIIB or RGEN: Which Is the Better Value Stock Right Now? - Nov 23rd, 2022 4:40 pm